EP Patent

EP2327724A3 — Modified human growth hormone polypeptides and their uses

Assigned to Ambrx Inc · Expires 2011-07-27 · 15y expired

What this patent protects

Modified human growth hormone polypeptides and uses thereof are provided.

USPTO Abstract

Modified human growth hormone polypeptides and uses thereof are provided.

Drugs covered by this patent

Patent Metadata

Patent number: EP2327724A3
Jurisdiction: EP
Classification: —
Expires: 2011-07-27
Drug substance claim: No
Drug product claim: No
Assignee: Ambrx Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.